Status:
COMPLETED
Pulmonary and Extrapulmonary Impacts of COVID-19 on Young Adults
Lead Sponsor:
Istanbul Arel University
Conditions:
Post COVID-19
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
When the literature search is conducted, it is seen that there are many studies examining the effects of COVID-19 disease on individuals in various disease groups (MS, stroke, Parkinson, COPD, asthma,...
Eligibility Criteria
Inclusion
- volunteers who are aged between 18-45 years
- cases, who were infected with COVID-19 and had at least 12 weeks after diagnosis
- cases, who have no symptoms of COVID-19 such as fever, cough, ageusia, anosmia, diarrhea, arthralgia, myalgia, sore throat, headache, chest pain
Exclusion
- those have any cardiac or pulmonary disease history
- those have diagnoses of any psychological disease (major depression, anxiety disorder, etc.)
- those have any neurological or orthopaedic disease which hinders participation in physical activity
Key Trial Info
Start Date :
April 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 5 2025
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT05282043
Start Date
April 4 2022
End Date
April 5 2025
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Arel University
Istanbul, Zeytinburnu, Turkey (Türkiye), 34010